Skip to main content

More pain in store for L&T

L&T will witness pressure on profitability both in core and non-core businesses such as IT and financial services

 

Highlights
June quarter severely impacted by Covid-19
- Stress could continue in September quarter, albeit at a slower pace
- Strong balance sheet and order book to support in the interim
- Expect flat or marginal growth this year

- Valuation offers little margins of safety

If Larsen & Toubro’s (CMP: Rs 916, Mcap: Rs 1,28,654 crore) June quarter results are any indication, it is clear that the stress in the engineering and construction space is much more than what the Street had initially expected. The pain because of the nationwide lockdown and the subsequent slowing of industrial activity was acute during the reporting quarter. It is likely to continue in the second quarter of the current financial year as well, albeit to a lesser degree.


“With the partial lifting of the lockdown and the graded resumption of business operations, the domestic economy is expected to improve incrementally over the next few quarters. Ordering activity in roads, urban infra particularly health care, railways, water distribution and waste-water treatment and irrigation sub-segments is expected to pick up in the later part of the fiscal year,” the L&T management has observed while giving out an outlook for the next few months.

No wonder the company skipped its revenue and profitability guidance, citing uncertainty. While its operations have resumed and offices are functioning, L&T expects the recovery to be gradual. In all probability, the current year would be one of consolidation and investors should keep expectations low.

Results at a glance

In the June quarter, the execution of orders has suffered because of the lockdown and most of L&T’s business segments have seen lower revenues. The company’s consolidated revenue dropped by 28 per cent on a year-on-year (YoY) basis.


The pain was largely reflected in L&T’s core business (excluding IT and financial services business), which saw a steep decline of 47 per cent on a YoY basis. The infrastructure business, which is close to 50 per cent of its core business, saw revenues dropping by more than 53 per cent. This segment suffered mostly because of non-availability of labour and disruption in the supply chain during the lockdown.

Segments such as heavy engineering, defence, electrical and automation also faced similar challenges. Client side issues and supply chain disruption led to a drop in revenues in these segments as well.

On the other hand, IT and financial services, which together account for 42 per cent of L&T’s total revenues, performed relatively better and helped in somewhat offsetting the pressure on the core business.

Operating performance

The profitability of L&T took a hit as the core business earned lower margins because of high operating costs and lower utilisations. During the June quarter, the group EBITDA (earnings before interest, tax, depreciation and amortisation) dropped 47 per cent and the EBITDA margin fell to 7.6 per cent as against 10.4 per cent in the corresponding period last year.

L&T’s largest segment, infrastructure, reported a 127.5-basis-point drop in EBIT to 3.8 per cent. The other notable contributor to the decline was the financial services business, whose EBITDA margins dropped to a piffling 3.6 per cent in the June quarter as against 22 per cent in the last fiscal. Though L&T has divested its wealth management business, the increased provisioning had put a pressure on profitability, dragging sharply down the reported profits of the overall group by 79 per cent on a YoY basis.

 

Earnings outlook

While L&T has not given any guidance, the stress in its core business will continue and contribution from other businesses such as financial services will remain lower. As a result, the first half of the year will be negative in terms of growth.

Though a recovery in the second half is likely, it may not be enough to recoup the loss in revenues during the first half. Thus we have estimated that this year the company will see a marginal 1-2 per cent revenue growth on a YoY basis. Pressure on profitability will remain both in the core business as well as noncore businesses such as IT and financial services. Hence, operating margins could drop marginally.

This also means pressure on return ratios and working capital this year. The company’s return on equity has already dropped to 12.7 per cent in Q1FY21 from 15.4 per cent in the corresponding quarter. Net working capital increased to 26.8 per cent of revenues as against 23.7 per cent in fiscal 2020 and 18.1 per cent in fiscal 2019. This means L&T would require additional cash for its business. This will drag down the overall treasury income earned on surplus cash and lower the return on capital. The only respite is that the balance sheet is strong and the company has a good amount of cash in its books, which should help in mitigating the stress.  

Thankfully, the order book remains healthy. During the reporting quarter, order inflows dropped 39 per cent on a YoY basis. However, it still continues to have good orders in hand of close to Rs 305100 crore, which is up by about 4 per cent on a YoY basis. As various issues triggered by the lockdown get sorted out towards the end of the current fiscal, execution should gather pace. This should lead to a better performance in fiscal 2022, when we are expecting L&T’s overall revenues to grow to the tune of 18-20 per cent.


Valuation

The company is sitting on a good amount of cash and leverage is under control, enabling it to navigate this crisis well. Because of a lack of growth this year, investors, in the interim, will have to live with low expectations particularly in the light of the valuations. The stock is now trading about 15 times its FY21 and 12 times FY22 estimated consolidated earnings. At the current price, valuations offer little margins of safety as some of the interim risks may not be adequately getting reflected in the price.

Source - Moneycontrol.com


Comments

Popular posts from this blog

Panacea Biotech shares hit 5% upper circuit after dengue vaccine completes phase I & II study

DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes, the company has said in an exchange filing. Panacea Biotech share price hit 5 percent upper circuit on the BSE on September 24 after the company completed phases I and II study of its dengue vaccine candidate DengiAIl. "Panacea Biotec Ltd. is delighted to announce the successful completion of its Phase I/II study to evaluate the safety and immunogenicity of its vaccine, DengiAll, a single-dose liveattenuated tetravalent vaccine," the company said in an exchange filing. Live-attenuated vaccines contain weakened bacteria or viruses that trigger an immune response but do not cause disease. The company said DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes. DengiAIl has been found to be safe and well-tolerated with no serious adverse effects, the company said. After a single-dose, more than 80 percent of the participants ...

Check Chemcon Speciality Chemicals IPO allotment status in four simple steps

Equity shares will get credited into the accounts of eligible investors by September 30 and the listing of equity shares will be on October 1, 2020. Chemcon Speciality Chemicals, the manufacturer for pharmaceutical and oilfields industries, is expected to announce the basis of allotment early next week. As per the schedule provided by the company, the finalisation of the basis of the allotment will be done by September 28 and the initiation of refunds or unblocking of funds from ASBA account will take place on September 29. Equity shares will get credited to the accounts of eligible investors by September 30 and the listing will be on October The IPO comprised a fresh issue of Rs 165 crore and an offer for sale of Rs 153 crore by promoters. The company will utilise fresh issue proceeds for expansion of manufacturing facility, working capital requirements, and general corporate purposes. Chemcon manufactures specialised chemicals, such as Hexamethyldisilazane (HMDS) and Chloromethyl Iso...

Taking Stock | Profit-booking pulls Nifty below 14,450; Sensex drops 549 points

  All the sectoral indices ended in the red with IT and PSU bank indices falling 2 percent each. The market remained under pressure on January 15 on the back of profit-booking across sectors amid weak global cues. At close, the Sensex was down 549.49 points or 1.11% at 49,034.67, and Nifty was down 161.90 points or 1.11% at 14,433.70. "The market witnessed profit-booking and following global trends. Nifty continues to resist 14,600 and has taken a dip towards 14,360. If the market closes below 14,380 levels, we might see a correction till the levels of 14,180-14,200. Momentum indicators like RSI, MACD are indicating a small correction in the markets," said Ashis Biswas, Head of Research at CapitalVia Global Research. All the sectoral indices ended in the red with IT and PSU bank falling 2 percent each. Broader markets performed in line with the main indices with BSE Midcap and Smallcap indices falling 1 percent each. Tech Mahindra, GAIL, HCL Tech, Wipro and ONGC...